*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Eli/NNP Lilly/NNP ]
&/CC 
[ Co./NNP ]
is/VBZ revamping/VBG 
[ quality-control/NN procedures/NNS ]
throughout/IN 
[ the/DT company/NN ]
following/VBG 
[ U.S./NNP inspectors/NNS '/POS discovery/NN ]
of/IN 
[ widespread/JJ quality-control/NN problems/NNS ]
at/IN 
[ an/DT Indianapolis/NNP drug/NN plant/NN ]
./. 

======================================

[ Lilly/NNP ]
wants/VBZ to/TO have/VB ``/`` 
[ good/JJ ]
,/, 
[ strong/JJ controls/NNS ]
over/IN 
[ the/DT whole/JJ thing/NN ]
because/IN 
[ we/PRP ]
do/VBP n't/RB want/VB 
[ more/JJR problems/NNS ]
to/TO emerge/VB ,/, ''/'' said/VBD 
[ Richard/NNP D./NNP Wood/NNP ]
,/, 
[ chairman/NN ]
of/IN 
[ the/DT pharmaceutical/JJ maker/NN ]
,/, in/IN 
[ an/DT interview/NN ]
here/RB 
[ Friday/NNP ]
./. 

[ The/DT steps/NNS ]
mark/VBP 
[ Lilly/NNP 's/POS first/JJ acknowledgment/NN ]
of/IN 
[ the/DT seriousness/NN ]
of/IN 
[ the/DT Indianapolis/NNP situation/NN ]
,/, 
[ which/WDT ]
arose/VBD from/IN 
[ a/DT U.S./NNP Food/NNP ]
and/CC 
[ Drug/NNP Administration/NNP investigation/NN ]
./. 

======================================

In/IN 
[ a/DT departure/NN ]
from/IN 
[ industry/NN practice/NN ]
,/, 
[ Lilly/NNP ]
now/RB will/MD oversee/VB 
[ quality/NN control/NN ]
from/IN 
[ its/PRP$ Indianapolis/NNP headquarters/NN ]
rather/RB than/IN leaving/VBG 
[ it/PRP ]
up/RP to/TO 
[ individual/JJ facilities/NNS ]
./. 

Centralizing/VBG 
[ responsibility/NN ]
means/VBZ ``/`` 
[ we/PRP ]
will/MD have/VB 
[ complete/JJ control/NN ]
at/IN 
[ the/DT corporate/JJ level/NN ]
,/, ''/'' 
[ Mr./NNP Wood/NNP ]
said/VBD ./. 

Before/IN ,/, ``/`` 
[ there/EX ]
was/VBD 
[ oversight/NN ]
but/CC 
[ no/DT direct-line/JJ responsibility/NN ]
''/'' for/IN 
[ monitoring/VBG production/NN quality/NN ]
./. 

[ Lilly/NNP ]
also/RB is/VBZ making/VBG 
[ some/DT management/NN changes/NNS ]
as/IN 
[ part/NN ]
of/IN 
[ this/DT overhaul/NN ]
,/, 
[ he/PRP ]
said/VBD ./. 

======================================

[ Last/JJ month/NN ]
,/, 
[ Lilly/NNP ]
halted/VBD 
[ the/DT distribution/NN ]
of/IN 
[ all/DT drugs/NNS ]
made/VBN at/IN 
[ the/DT Indianapolis/NNP plant/NN ]
and/CC recalled/VBD 
[ 10/CD drugs/NNS ]
after/IN 
[ FDA/NNP inspectors/NNS ]
sharply/RB criticized/VBD 
[ quality-control/NN procedures/NNS ]
./. 

[ The/DT problems/NNS ]
centered/VBD on/IN 
[ submission/NN ]
of/IN 
[ false/JJ ]
or/CC 
[ incomplete/JJ data/NNS ]
,/, 
[ poor/JJ record/NN ]
keeping/NN and/CC 
[ Lilly/NNP 's/POS failure/NN ]
to/TO adequately/RB train/VB 
[ quality-control/NN officers/NNS ]
./. 

======================================

[ The/DT FDA/NNP 's/POS report/NN ]
triggered/VBD 
[ a/DT separate/JJ probe/NN ]
by/IN 
[ the/DT investigations/NNS subcommittee/NN ]
of/IN 
[ the/DT U.S./NNP House/NNP Energy/NNP ]
and/CC 
[ Commerce/NNP Committee/NNP ]
./. 

[ The/DT panel/NN ]
wants/VBZ to/TO learn/VB whether/IN 
[ Lilly/NNP ]
filed/VBD 
[ false/JJ ]
or/CC 
[ misleading/JJ information/NN ]
with/IN 
[ the/DT FDA/NNP ]
about/IN 
[ its/PRP$ manufacturing/NN processes/NNS ]
in/IN 
[ Indianapolis/NNP ]
./. 

In/IN 
[ addition/NN ]
,/, 
[ the/DT FDA/NNP ]
now/RB is/VBZ looking/VBG at/IN 
[ three/CD other/JJ Lilly/NNP drug/NN plants/NNS ]
in/IN 
[ Puerto/NNP Rico/NNP ]
to/TO determine/VB whether/IN 
[ they/PRP ]
have/VBP 
[ problems/NNS ]
like/IN 
[ the/DT ones/NNS ]
found/VBN in/IN 
[ Indianapolis/NNP ]
./. 

[ Lilly/NNP officials/NNS ]
have/VBP tended/VBN to/TO downplay/VB 
[ the/DT Indianapolis/NNP plant/NN 's/POS problems/NNS ]
as/RB largely/RB 
[ technical/JJ aberrations/NNS ]
./. 

[ The/DT company/NN ]
hopes/VBZ 
[ the/DT facility/NN ]
``/`` will/MD shortly/RB resume/VB 
[ full/JJ production/NN ]
and/CC 
[ shipment/NN ]
,/, ''/'' 
[ Mr./NNP Wood/NNP ]
told/VBD 
[ a/DT group/NN ]
of/IN 
[ U.K./NNP analysts/NNS ]
and/CC 
[ fund/NN managers/NNS ]
here/RB ./. 

======================================

As/IN 
[ part/NN ]
of/IN 
[ the/DT quality-control/NN shakeup/NN ]
,/, 
[ Mr./NNP Wood/NNP ]
said/VBD 
[ Robert/NNP Williams/NNP ]
has/VBZ assumed/VBN 
[ the/DT new/JJ post/NN ]
of/IN 
[ vice/NN president/NN ]
for/IN 
[ quality/NN control/NN ]
./. 

[ Mr./NNP Williams/NNP ]
previously/RB was/VBD 
[ Lilly/NNP 's/POS vice/NN president/NN ]
of/IN 
[ agricultural/JJ research/NN ]
./. 

[ Two/CD other/JJ Lilly/NNP executives/NNS ]
involved/VBN with/IN 
[ directing/VBG quality/NN control/NN ]
or/CC 
[ the/DT Indianapolis/NNP facility/NN ]
have/VBP been/VBN demoted/VBN to/TO 
[ less/RBR responsible/JJ jobs/NNS ]
,/, 
[ the/DT Lilly/NNP chairman/NN ]
indicated/VBD ./. 
